Syros Pharmaceuticals to Present at JMP Securities 2021 Life Sciences Conference

Rhea-AI Summary

Syros Pharmaceuticals (NASDAQ:SYRS) announced that CEO Nancy Simonian, M.D., will participate in a fireside chat at the JMP Securities 2021 Life Sciences Conference on June 16 at 1:00 p.m. ET. A live webcast will be available on the Syros website, with an archived replay accessible for 30 days post-event. Syros focuses on innovative gene expression control with a robust clinical pipeline, including SY-1425 for myelodysplastic syndrome, SY-2101 for acute promyelocytic leukemia, and SY-5609 for solid tumors.

Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that its Chief Executive Officer, Nancy Simonian, M.D., will participate in a fireside chat at the JMP Securities 2021 Life Sciences Conference. Details are as follows:

JMP Securities 2021 Life Sciences Conference:
Date: Wednesday, June 16
Time: 1:00 p.m. ET

A live webcast of the presentation will be available on the Investors & Media section of the Syros website at www.syros.com. An archived replay of the webcast will be available for approximately 30 days following the presentation.

About Syros Pharmaceuticals
Syros is redefining the power of small molecules to control the expression of genes. Based on its unique ability to elucidate regulatory regions of the genome, Syros aims to develop medicines that provide a profound benefit for patients with diseases that have eluded other genomics-based approaches. Syros is advancing a robust clinical-stage pipeline, including: SY-1425, a first-in-class oral selective RARα agonist in RARA-positive patients with higher-risk myelodysplastic syndrome and acute myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide in patients with acute promyelocytic leukemia; and SY-5609, a highly selective and potent oral CDK7 inhibitor in patients with select solid tumors. Syros also has multiple preclinical and discovery programs in oncology and monogenic diseases. For more information, visit www.syros.com and follow us on Twitter (@SyrosPharma) and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210609005086/en/

FAQ

When is the JMP Securities 2021 Life Sciences Conference for Syros Pharmaceuticals (SYRS)?

The conference is on June 16 at 1:00 p.m. ET.

Where can I watch the webcast of Syros Pharmaceuticals (SYRS) at the JMP Securities Conference?

The live webcast will be available on the Investors & Media section of Syros' website.

What is Syros Pharmaceuticals' (SYRS) focus in drug development?

Syros focuses on controlling gene expression, with a pipeline targeting diseases like myelodysplastic syndrome and acute leukemia.

How long will the archived webcast of Syros Pharmaceuticals (SYRS) event be available?

The archived replay will be available for approximately 30 days after the presentation.